Monitoring of measurable residual disease by next-generation sequencing in patients with acute myeloid leukaemia.

NGS‐MRD positivity did not reach statistical significance either for PC1 or for PC2 when all mutations were included (Figure S3A,B ) or when only DTA mutations were excluded (Figure S3C,D ).

also in 111,027 other papers